Glenn Walker

936 total citations
12 papers, 659 citations indexed

About

Glenn Walker is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Glenn Walker has authored 12 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Glenn Walker's work include Neuroscience and Neuropharmacology Research (5 papers), Cannabis and Cannabinoid Research (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Glenn Walker is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Cannabis and Cannabinoid Research (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Glenn Walker collaborates with scholars based in United Kingdom, Australia and India. Glenn Walker's co-authors include Phillip M. Cowley, Richard Goodwin, Adèle Thomas, Fiona Thomson, Gillian Goodwin, Julia Marrs, Paul Westwood, Lesley Stevenson, Lorraine McIntosh and Arthur Christopoulos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, FEBS Letters and Neuroscience.

In The Last Decade

Glenn Walker

12 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn Walker United Kingdom 8 371 361 248 92 53 12 659
М. Yu. Bobrov Russia 12 325 0.9× 186 0.5× 545 2.2× 33 0.4× 17 0.3× 52 861
Nicolette C. Ross United States 12 473 1.3× 603 1.7× 61 0.2× 32 0.3× 41 0.8× 12 778
Brian I. Knapp United States 16 402 1.1× 433 1.2× 81 0.3× 28 0.3× 27 0.5× 35 683
Marc P. Baggelaar Netherlands 16 160 0.4× 281 0.8× 459 1.9× 48 0.5× 12 0.2× 29 815
Edward Hyde United States 13 143 0.4× 276 0.8× 157 0.6× 24 0.3× 29 0.5× 19 772
Sui‐Po Zhang United States 19 416 1.1× 537 1.5× 119 0.5× 46 0.5× 7 0.1× 45 976
Richard W. Zink United States 11 149 0.4× 243 0.7× 65 0.3× 24 0.3× 17 0.3× 19 523
Klaus Schicker Austria 20 481 1.3× 532 1.5× 43 0.2× 51 0.6× 9 0.2× 40 843
Samuel Obeng United States 16 252 0.7× 314 0.9× 107 0.4× 282 3.1× 20 0.4× 40 744
Luz Cortes-Burgos United States 9 142 0.4× 410 1.1× 99 0.4× 23 0.3× 17 0.3× 10 558

Countries citing papers authored by Glenn Walker

Since Specialization
Citations

This map shows the geographic impact of Glenn Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Walker more than expected).

Fields of papers citing papers by Glenn Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Walker. The network helps show where Glenn Walker may publish in the future.

Co-authorship network of co-authors of Glenn Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Walker. A scholar is included among the top collaborators of Glenn Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Walker. Glenn Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Maclean, John, Darren Edwards, Katy L. Everett, et al.. (2011). Identification of potent, soluble, and orally active TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(8). 2559–2563. 19 indexed citations
2.
Cowley, Phillip M., James Α. Baker, John K. Clark, et al.. (2011). Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(7). 2034–2039. 3 indexed citations
3.
Cowley, Phillip M., James Α. Baker, John K. Clark, et al.. (2010). The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(1). 497–501. 6 indexed citations
4.
Bingham, Matilda, Richard Goodwin, Anders Haunsø, et al.. (2010). The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain. Bioorganic & Medicinal Chemistry Letters. 21(1). 271–275. 3 indexed citations
5.
Kiyoi, Takao, Mark York, Darren Edwards, et al.. (2010). Design, synthesis, and structure–activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(16). 4918–4921. 11 indexed citations
6.
Moir, Elizabeth M., Phillip M. Cowley, Morag Ferguson, et al.. (2010). Design, synthesis, and structure–activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(24). 7327–7330. 16 indexed citations
7.
Andrews, Nancy C., Jin Ge, Glenn Walker, J. Schipper, & Hugh Marston. (2007). P.3.f.002 Effect of the selective glycine re-uptake (GlyT-1) inhibitor Org 25935 on glycine levels in CSF and dialysates. European Neuropsychopharmacology. 17. S497–S498. 3 indexed citations
8.
Baillie, Gemma L., Adèle Thomas, Lesley Stevenson, et al.. (2005). Allosteric Modulation of the Cannabinoid CB1 Receptor. Molecular Pharmacology. 68(5). 1484–1495. 348 indexed citations
9.
Whitehead, Kevin J., et al.. (2004). Positive N-methyl-d-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo. Neuroscience. 126(2). 381–390. 34 indexed citations
10.
Hammer, Mary‐Anne, et al.. (2003). The glycine neurotransmitter transporter GLYT1 is an organic osmolyte transporter regulating cell volume in cleavage-stage embryos. Proceedings of the National Academy of Sciences. 100(24). 13982–13987. 85 indexed citations
11.
Brown, Angus R., John R. Clark, William Hamilton, et al.. (2001). Discovery and SAR of Org 24598—A Selective Glycine Uptake Inhibitor. Bioorganic & Medicinal Chemistry Letters. 11(15). 2007–2009. 75 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by М. Yu. Bobrov Breakdown of academic impact, for papers by Nicolette C. Ross Breakdown of academic impact, for papers by Brian I. Knapp Breakdown of academic impact, for papers by Marc P. Baggelaar Breakdown of academic impact, for papers by Edward Hyde Breakdown of academic impact, for papers by Sui‐Po Zhang Breakdown of academic impact, for papers by Richard W. Zink Breakdown of academic impact, for papers by Klaus Schicker Breakdown of academic impact, for papers by Samuel Obeng Breakdown of academic impact, for papers by Luz Cortes-Burgos
Rankless by CCL
2026